UNSPSC 51342003: Pleconaril

This classification denotes an anti-infective agent with the molecular formula C18H18F3N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9H4570Q89D, chemically known as 1,2,4-oxadiazole, 3-(3,5-dimethyl-4-(3-(3-methyl-5-isoxazolyl)propoxy)phenyl)-5-(trifluoromethyl)- but generally known as pleconaril, which bears US NIH Compound Identifier 1684. European Medicines Agency schedules Pleconaril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09957MIG.

UNSPSC 51342003 Pleconaril is a Commodity code for a specific antiviral pharmaceutical product, yet the recent state and local opportunities tagged under it show little activity directly aligned with pleconaril procurement. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride), and Seminole County, Florida posted an IFB in June 2026 for naloxone and drug deactivation systems — neither of which is pleconaril. The opportunities demonstrate that state and local health departments use cooperative purchasing vehicles and piggyback contracts to source pharmaceuticals and medical supplies through streamlined processes, but the specific pleconaril product itself does not appear in these recent postings.

The geographic spread of pharmaceutical procurement activity spans at least Florida and Illinois, with the Illinois contract serving the state's public health emergency preparedness function and the Seminole County procurement supporting community health and harm-reduction initiatives. The source provides no recent open solicitations actively seeking pleconaril as a line item. The mismatch between the code's nominal scope and the recent opportunities tagged to it suggests either light procurement activity under this specific Commodity code or tagging inconsistency within state and local procurement systems. Business development professionals should monitor for future state health department emergency preparedness and pandemic response solicitations where antiviral pharmaceuticals like pleconaril may be requested, particularly through cooperative purchasing consortiums, but current activity under this code does not reflect active demand for the product.